Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II adjuvant FOLFOX with concurrent radiotherapy after gastric cancer surgery
ChiCTR-ONC-12001918Phase 2Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jul 2011
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of oxaliplatin, fluorouracil and folinic acid in gastric cancer (GC), sponsored by West China Hospital of Sichuan University. Primary endpoints: Disease-free survival and Overall survival. Started Jul 2011; status: completed.
02
Drugs
oxaliplatinfluorouracilfolinic acid
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on ChiCTR-ONC-12001918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-12001918.